27.3 C
New York
Thursday, June 11, 2026

Tag: oral molecule

vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

•   First study participant randomized in Phase 3 CATT1 trial evaluating cadisegliatin for the treatment of type 1 diabetes with data expected in second half of 2026

- A word from our sponsors -

spot_img
HomeTagsOral molecule